HORN HOWARD (Chief Financial Officer) sold 4.2% of their position (4.65K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $110.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/1/2026ACC: 0001786335-26-000002
Officer· Chief Financial Officer
Since Mar 2026
-4.65K
Net shares
Net seller
$110.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.65K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.65K
Price / share
$23.77
Trade value
$110.60K
% of position
4.2%
6/1/2026
110.34K→105.69K
Total
Net shares
−4.65K
Net value
-$110.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | S · Sale | −4.65K | $23.77 | $110.60K | 4.2% | 110.34K | 105.69K |
| Total | −4.65K | -$110.60K | ||||||
Derivative Transactions0
No derivative transactions reported